COGT
Conviction 34HealthcareScan · Thu, Sep 24, 2026Cogent Biosciences, Inc. (COGT) closed at $31.41 (+0.00%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 34, RS Rating 97, -26.7% from its 52-week high, -9.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJul 151 scan
- Breaking out nowJul 301 scan
Congress activity
Disclosed STOCK Act trades in COGT
Insider activity
SEC Form 4 transactions in COGT · open-market 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Morris Arlene Director · Common Stock · 2026-08-27 | Exercise | 41.93K | $236K | 2026-08-27 | 2026-08-31 |
Morris Arlene Director · Common Stock · 2026-08-27 | Exercise | 3.58K | $9K | 2026-08-27 | 2026-08-31 |
Morris Arlene Director · Common Stock · 2026-08-27 | Sell | 42.35K | $1.6M | 2026-08-27 | 2026-08-31 |
Morris Arlene Director · Common Stock · 2026-08-27 | Sell | 3.16K | $119K | 2026-08-27 | 2026-08-31 |
Morris Arlene Director · Stock Option (Right to Buy) · 2026-08-27 | Exercise | 41.93K | — | 2026-08-27 | 2026-08-31 |
Morris Arlene Director · Stock Option (Right to Buy) · 2026-08-27 | Exercise | 3.58K | — | 2026-08-27 | 2026-08-31 |
Robbins Andrew R President and CEO · Common Stock · 2026-05-19 | Gift | 160K | $0 | 2026-05-19 | 2026-05-21 |
Robbins Andrew R President and CEO · Common Stock · 2026-05-19 | Gift | 160K | $0 | 2026-05-19 | 2026-05-21 |
SEC filings
EDGAR filings in COGT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.